Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich Posts 12-Percent Rise in Q1 Revenue; Profit Increases 13 Percent

NEW YORK (GenomeWeb News) —Sigma-Aldrich today said first-quarter revenue increased 12 percent as R&D spending rose 8 percent and net income increased 13 percent.
 
Total receipts for the three months ended March 31 rose to $495.9 million from $443.1 million year over year.
 
Revenue from Sigma’s Research Essentials division increased to $98.8 million from $91.8 million; Research Specialties receipts jumped to $189.3 million from $168.8 million; and Research Biotech revenue increased to $75.2 million from $71.8 million.
 
Sigma-Aldrich CEO, Jai Nagarkatti, said the addition of Epichem in February “provides two-thirds of our annual goal to add 3 percentage points of growth through acquisitions this year.”
 
R&D spending increased to $14.1 million from $13 million year over year.
 
The company said profit increased to $74.9 million $66.5 million in the year-ago period.
 
Sigma-Aldrich said it had around $173 million in cash and equivalents as of March 31.
 
The company reaffirmed last quarter’s expectation that 2007 revenues should increase roughly 7 percent year over year. Sigma-Aldrich expects sales in Research Specialties to exceed its 6-percent growth goal for the full year, with organic sales growth expected to be around 7 percent.
 
The company is forecasting its Research Biotech division to see growth “toward the lower end” of the 7- to 9-percent range, and holds to its expectation that its SAFC growth should be around 10 percent. Growth in Research Essentials is expected to be around 4 percent.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.